Dashboard
Manage Tickers

DXCM DEXCOM INC

Nasdaq dexcom.com


$ 68.22 $ -1.05 (-1.52 %)    

Wednesday, 29-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 68.18
$ 68.92
$ 67.00 x 33
$ 69.10 x 16
$ 67.80 - $ 69.10
$ 57.52 - $ 93.25
4,434,808
na
26.74B
$ 1.35
$ 46.78
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-14-2025 12-31-2024 10-K
4 10-24-2024 09-30-2024 10-Q
5 07-25-2024 06-30-2024 10-Q
6 04-25-2024 03-31-2024 10-Q
7 02-08-2024 12-31-2023 10-K
8 10-26-2023 09-30-2023 10-Q
9 07-27-2023 06-30-2023 10-Q
10 04-27-2023 03-31-2023 10-Q
11 02-09-2023 12-31-2022 10-K
12 10-27-2022 09-30-2022 10-Q
13 07-28-2022 06-30-2022 10-Q
14 04-28-2022 03-31-2022 10-Q
15 02-14-2022 12-31-2021 10-K
16 10-28-2021 09-30-2021 10-Q
17 07-29-2021 06-30-2021 10-Q
18 04-29-2021 03-31-2021 10-Q
19 02-11-2021 12-31-2020 10-K
20 10-27-2020 09-30-2020 10-Q
21 07-28-2020 06-30-2020 10-Q
22 04-28-2020 03-31-2020 10-Q
23 02-13-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-01-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-01-2017 09-30-2017 10-Q
33 08-01-2017 06-30-2017 10-Q
34 05-02-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 11-01-2016 09-30-2016 10-Q
37 08-02-2016 06-30-2016 10-Q
38 04-27-2016 03-31-2016 10-Q
39 02-23-2016 12-31-2015 10-K
40 11-04-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

an-overview-of-dexcoms-earnings
An Overview of DexCom's Earnings
10/29/2025 17:02:47

dexcom-faces-new-reports-of-deaths-linked-to-g7-glucose-monitor
DexCom Faces New Reports Of Deaths Linked ...
10/28/2025 18:04:53

Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.

watching-dexcom-shares-spike-lower-hunterbrook-issues-report-titled-three-more-deaths-reported-after-dexcom-g7-faults
Watching DexCom; Shares Spike Lower, Hunte...
10/28/2025 15:01:57

https://hntrbrk.com/dexcom-2/

forecasting-the-future-13-analyst-projections-for-dexcom
Forecasting The Future: 13 Analyst Project...
10/21/2025 22:02:03

stifel-reinstates-buy-on-dexcom-announces-85-price-target
Stifel Reinstates Buy on DexCom, Announces...
10/21/2025 13:51:17

Stifel analyst Jonathan Block reinstates DexCom (NASDAQ:DXCM) with a Buy and announces $85 price target.

truist-securities-maintains-buy-on-dexcom-lowers-price-target-to-94
Truist Securities Maintains Buy on DexCom,...
10/15/2025 15:11:58

Truist Securities analyst Richard Newitter maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $102 t...

dexcom-option-alert-nov-7-71-calls-at-the-ask-3000--279-vs-1-oi-earnings-1030-after-close-ref65735
DexCom Option Alert: Nov 7 $71 Calls At Th...
10/08/2025 14:15:55

citigroup-maintains-buy-on-dexcom-lowers-price-target-to-85
Citigroup Maintains Buy on DexCom, Lowers ...
10/07/2025 16:59:45

Citigroup analyst Joanne Wuensch maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $105 to $85.

goldman-sachs-maintains-buy-on-dexcom-lowers-price-target-to-89
Goldman Sachs Maintains Buy on DexCom, Low...
10/01/2025 17:34:08

Goldman Sachs analyst Kate McShane maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $104 to $89.

health-care-stocks-rally-nike-beats-the-street-whats-moving-markets-wednesday
Health Care Stocks Rally, Nike Beats The S...
10/01/2025 16:56:36

Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps m...

canaccord-genuity-maintains-buy-on-dexcom-maintains-106-price-target
Canaccord Genuity Maintains Buy on DexCom,...
09/29/2025 13:59:16

Canaccord Genuity analyst William Plovanic maintains DexCom (NASDAQ: DXCM) with a Buy and maintains $106 price target.

forecasting-the-future-10-analyst-projections-for-dexcom
Forecasting The Future: 10 Analyst Project...
09/26/2025 18:00:25

10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opin...

baird-maintains-outperform-on-dexcom-lowers-price-target-to-90
Baird Maintains Outperform on DexCom, Lowe...
09/26/2025 13:18:55

Baird analyst Jeff Johnson maintains DexCom (NASDAQ: DXCM) with a Outperform and lowers the price target from $112 to $90.

which-stocks-win-when-rates-fall-goldman-picks-these-surprising-names
Which Stocks Win When Rates Fall? Goldman ...
09/22/2025 14:34:02

darden-humana-and-rocket-lab-are-among-top-10-large-cap-losers-last-week-sep-15--sep-19-are-the-others-in-your-portfolio
Darden, Humana, And Rocket Lab Are Among T...
09/21/2025 11:31:55

Darden, Humana, Rocket Lab, and FactSet led last week's large-cap losers, with declines driven by weak earnings, guidance, ...

wall-street-extends-gains-apple-jumps-to-highest-since-february-whats-moving-markets-friday
Wall Street Extends Gains, Apple Jumps To ...
09/19/2025 17:29:32

Wall Street kept driving equity valuations higher on Friday, extending the momentum from Thursday when all major U.S. benchmark...

short-report-alleges-dexcom-sold-faulty-g7-device-cited-by-fda
Short Report Alleges Dexcom Sold Faulty G7...
09/18/2025 14:57:39

Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from Abbot...

watching-dexcom-shares-hunterbrook-capital-issues-short-report
Watching DexCom Shares, Hunterbrook Capita...
09/18/2025 13:10:21

fda-issues-update-to-continuous-glucose-monitor-apps-correction-dexcom-inc-issues-correction-for-g7-apps-and-one-apps-due-to-a-software-design-error-that-does-not-alert-users-of-unexpected-sensor-failure
FDA Issues Update To 'Continuous Glucose M...
09/15/2025 20:12:29

https://www.fda.gov/medical-devices/medical-device-recalls/continuous-glucose-monitor-apps-correction-dexcom-inc-issues-correct...

continuous-glucose-monitor-apps-correction-dexcom-inc-issues-correction-for-g7-apps-and-one-apps-due-to-a-software-design-error-that-does-not-alert-users-of-unexpected-sensor-failure---fda
'Continuous Glucose Monitor Apps Correctio...
09/12/2025 19:15:55

https://www.fda.gov/medical-devices/medical-device-recalls/continuous-glucose-monitor-apps-correction-dexcom-inc-issues-correct...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION